Home > Healthcare > Medical Devices > Surgical Devices > surgical pledgets market
Get a free sample of Surgical Pledgets Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Surgical Pledgets Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Cardiovascular conditions, including coronary artery disease, heart failure, and valvular diseases, are becoming increasingly common due to factors such as aging populations, poor lifestyle choices, and rising rates of obesity and diabetes. As a result, the demand for cardiovascular surgeries, including coronary artery bypass graft (CABG), heart valve repair, and other procedures, has surged. Surgical pledgets play a crucial role in these surgeries by reinforcing sutures, controlling bleeding, and supporting tissue during the closure process, which is essential for minimizing complications and promoting effective healing.
The global surgical pledgets industry was valued at USD 768.2 million in 2024 and is projected to grow at a CAGR of 5.7% from 2025 to 2034, driven by the increasing number of surgical procedures worldwide.
The PTFE segment is expected to grow at a CAGR of 6.1%, reaching over USD 593.3 million by 2034, due to its superior biocompatibility, chemical resistance, and low friction, making it ideal for surgeries requiring minimal tissue irritation and effective wound closure.
The U.S. surgical pledgets market was valued at USD 255 million in 2024 and is anticipated to grow at a CAGR of 4.5% from 2025 to 2034, driven by the rising prevalence of chronic diseases such as cardiovascular conditions, diabetes, and obesity.
Key players in the market include B. Braun, Becton, Dickinson and Company, DeRoyal, Dolphin Sutures, Gore, Henry Schein, Johnson and Johnson, Medline, Medtronic, Peters Surgical, and Teleflex.